نتایج جستجو برای: drug safety evaluation

تعداد نتایج: 1576394  

Journal: :international journal of hematology-oncology and stem cell research 0
elnaz sakhaiyan clinical pharmacist; faculty of pharmacy, medical sciences/ university of tehran, tehran, iran molouk hadjibabaie clinical pharmacist; faculty of pharmacy, medical sciences/ university of tehran, tehran, iran kheirollah gholami clinical pharmacist; faculty of pharmacy, medical sciences/ university of tehran, tehran, iran fanak fahimi clinical pharmacist; faculty of pharmacy, medical sciences/ university of shahid beheshti, tehran ahmad reza shamshiri epidemiologist, dep. of epidemiology and biostatistics, faculty of health and institute of health re kamran alimoghaddam hematology- oncology and stem cell transplantation research center, shariati hospital, tehran univer

introduction: drug utilization evaluation (due) studies are designed to assess drug usage appropriateness. dues have traditionally focused on drugs with high price tags, complicated dosage schedules, narrow therapeutic indices and regular side effects. the primary goal of the present study is to evaluate imipenem usage in bone marrow transplantation (bmt) wards. methods: the study was a prospec...

Journal: :Annals of the Academy of Medicine, Singapore 2000
V M Oh

Are medicines dangerous chemicals or life enhancing agents? The answer is ‘Both of those things, often at the same time, and worse in the wrong hands’. In this issue of the Annals, several authors address the problems besetting specialists who assess drug efficacy and safety. The last two articles describe activities (pharmacogenetics, and engineered drug delivery) which may produce unforeseen ...

2013
King-Fai Cheng Ping-Chung Leung

Safety of drugs is a common concern, regardless of traditional Chinese medicine or Western medicine. Historical experiences tell us that ignored drug safety evaluation would lead to serious consequences. Although Chinese medicine has been used for thousands of years, re-evaluation of the safety is still very important. The criteria for safety of Chinese herbal medicines should be the same as th...

Journal: :medical journal of islamic republic of iran 0
m barzegar thedept. of pediatric neurology, tabriz children hospital, tabriz university of medical sciences, tabriz, i.r. iran. sh tonekaboni from the department of pediatrics neurology, mofid children hospital, shahid beheshti university of medical sciences, tehran m ghofrani from the department of pediatrics neurology, mofid children hospital, shahid beheshti university of medical sciences, tehran

lamotrigine (ltg), a newly developed antiepileptic drug (aed), is efficacious in treating refractory epilepsy. this study was designed to evaluate the efficacy and safety of ltg as add-on therapy in 40 children with refractory epilepsy. the trial was an open-labeled prospective study in children with drug-resistant epilepsy aged <14 years, who had at least 4 seizures per month in spite of recei...

Journal: :Journal of Dermatological Treatment 2009

Journal: :Clinical chemistry 1979
J F Dooley

In the last decade, 149 new ethical drug entities have been placed in the hands of the American medical community (1). In each case the two critical determinants to the success or failure of each new compound as a viable product were safety and efficacy. Such data ultimately can only come from trials in patients. However, this must always be preceded by evaluations of safety in animals. It is t...

2017
Hokyung Oh Jinho Shin Manabu Ato Xiao Ma David Williams Kiwon Han Yang Jin Kim Hyunggoo Kang Kikyung Jung Kentaro Hanada Masaki Ochiai Pham Van Hung Sangmi Park Chiyoung Ahn

Blood Products Division, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Cheongju, Korea World Health Organization, Regional Office for the Western Pacific, Manila, Philippines National Institute of Infectious Diseases, Tokyo, Japan National Institutes for Food and Drug Control, China Food and Drug Administration, Beijing, China Department of Pharmacolog...

2010
Dong Lu Wenlong Huang

Developing a drug requires great amount of research work in chemistry, manufacturing, controls (CMC), preclinical science and clinical trials. Drug reviewers in regulatory agencies around the world bear the responsibility of evaluating whether the research data support the safety, effectiveness and quality control of a new drug product to serve the public health. This article provides an overvi...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید